表紙
市場調查報告書

自我輸血設備的全球市場:2020年∼2024年

Autotransfusion Devices Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 917059
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
自我輸血設備的全球市場:2020年∼2024年 Autotransfusion Devices Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月10日內容資訊: 英文 151 Pages
簡介

全球自我輸血設備市場上,心血管手術和整形外科手術的增加,移植手術的需求增加,同類輸血相關的併發症等成為要素,在預測期間內預計將以約6%的年複合成長率擴大。但,自我輸血伴隨的高成本,頻繁的產品回收,限制及替代品的存在等要素,可能妨礙在預測期間內自我輸血設備產業的成長。

本報告提供全球自我輸血設備市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2019年∼2024年)
  • 系統
  • 配件
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 事業策略
  • 技術的進步
  • 同類輸血相關的風險相關意識的高漲

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Becton, Dickinson, and Co.
  • Brightwake Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Haemonetics Corp.
  • LivaNova Plc
  • Medtronic Plc
  • Redax Spa
  • Teleflex Inc.
  • Zimmer Biomet Holdings Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40094

About this market

Technavio's autotransfusion devices market analysis considers sales from both systems and accessories products. Our study also finds the sales of autotransfusion devices in Asia, Europe, North America, and ROW. In 2019, the systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing medical complications with allogeneic blood transfusion will play a significant role in the systems segment to maintain its market position. Also, our global autotransfusion devices market report looks at factors such as the rising number of cardiac and orthopedic surgeries, increasing demand for transplantation procedures, and complications related to allogeneic blood transfusion. However, high costs associated with autotransfusion, frequent product recalls, and limitations and presence of substitutes may hamper the growth of the autotransfusion devices industry over the forecast period.

Overview

Rising number of surgeries

Blood transfusion is one of the key procedures to be performed during the intraoperative or postoperative procedures. Allogenic blood transfusion is mainly performed during the procedures, which may lead to various bacterial and viral infections. As a result, to avoid the risk of infection, autologous transfusions are being performed during these surgical procedures. Thus, an increase in various surgical procedures will lead to the expansion of the global autotransfusion devices market at a CAGR of almost 6% during the forecast period.

Technological advances

The procurement and maintenance of medical equipment account for a significant part of a healthcare organization's operational expenses. However, the growing technological innovation has enabled a paradigm shift in cost as well as the manageability of medical equipment. For instance, the launch of wearable devices has made patient monitoring much simpler and cost-effective and contributes to higher patient adherence to health monitoring. Thus, all these factors have the potential to accelerate the growth of the global healthcare equipment market, including the global autotransfusion devices market. Moreover, several companies focus on the development of technological platforms that are integrated with autotransfusion systems to provide blood products to patients during surgical procedures This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global autotransfusion devices market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of a few major players, the global autotransfusion devices market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading autotransfusion device manufacturers, that include Becton, Dickinson and Co., Brightwake Ltd., Fresenius Medical Care AG & Co. KGaA, Getinge AB, Haemonetics Corp., LivaNova Plc, Medtronic Plc, Redax Spa, Teleflex Inc., and Zimmer Biomet Holdings Inc.

Also, the autotransfusion devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Systems - Market size and forecast 2019-2024
  • Accessories - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Business strategies
  • Technological advances
  • Growing awareness about risks related to allogeneic blood transfusion

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Becton, Dickinson, and Co.
  • Brightwake Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Haemonetics Corp.
  • LivaNova Plc
  • Medtronic Plc
  • Redax Spa
  • Teleflex Inc.
  • Zimmer Biomet Holdings Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Systems - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Systems - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Accessories - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Accessories - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Product recalls
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Business strategies and their market impact analysis
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 47: Becton, Dickinson and Co. - Business segments
  • Exhibit 48: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 49: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 50: Becton, Dickinson and Co. - Segment focus
  • Exhibit 51: Becton, Dickinson and Co. - Key offerings
  • Exhibit 52: Becton, Dickinson and Co. - Key customers
  • Exhibit 53: Brightwake Ltd. - Vendor overview
  • Exhibit 54: Brightwake Ltd. - Product segments
  • Exhibit 55: Brightwake Ltd. - Key offerings
  • Exhibit 56: Brightwake Ltd. - Key customers
  • Exhibit 57: Fresenius Medical Care AG & Co. KGaA - Vendor overview
  • Exhibit 58: Fresenius Medical Care AG & Co. KGaA - Business segments
  • Exhibit 59: Fresenius Medical Care AG & Co. KGaA - Organizational developments
  • Exhibit 60: Fresenius Medical Care AG & Co. KGaA - Geographic focus
  • Exhibit 61: Fresenius Medical Care AG & Co. KGaA - Segment focus
  • Exhibit 62: Fresenius Medical Care AG & Co. KGaA - Key offerings
  • Exhibit 63: Fresenius Medical Care AG & Co. KGaA - Key customers
  • Exhibit 64: Getinge AB - Vendor overview
  • Exhibit 65: Getinge AB - Business segments
  • Exhibit 66: Getinge AB - Organizational developments
  • Exhibit 67: Getinge AB - Geographic focus
  • Exhibit 68: Getinge AB - Segment focus
  • Exhibit 69: Getinge AB - Key offerings
  • Exhibit 70: Getinge AB - Key customers
  • Exhibit 71: Haemonetics Corp. - Vendor overview
  • Exhibit 72: Haemonetics Corp. - Business segments
  • Exhibit 73: Haemonetics Corp. - Organizational developments
  • Exhibit 74: Haemonetics Corp. - Geographic focus
  • Exhibit 75: Haemonetics Corp. - Segment focus
  • Exhibit 76: Haemonetics Corp. - Key offerings
  • Exhibit 77: Haemonetics Corp. - Key customers
  • Exhibit 78: LivaNova Plc - Vendor overview
  • Exhibit 79: LivaNova Plc - Business segments
  • Exhibit 80: LivaNova Plc - Organizational developments
  • Exhibit 81: LivaNova Plc - Geographic focus
  • Exhibit 82: LivaNova Plc - Segment focus
  • Exhibit 83: LivaNova Plc - Key offerings
  • Exhibit 84: LivaNova Plc - Key customers
  • Exhibit 85: Medtronic Plc - Vendor overview
  • Exhibit 86: Medtronic Plc - Business segments
  • Exhibit 87: Medtronic Plc - Organizational developments
  • Exhibit 88: Medtronic Plc - Geographic focus
  • Exhibit 89: Medtronic Plc - Segment focus
  • Exhibit 90: Medtronic Plc - Key offerings
  • Exhibit 91: Medtronic Plc - Key customers
  • Exhibit 92: Redax Spa - Vendor overview
  • Exhibit 93: Redax Spa - Product segments
  • Exhibit 94: Redax Spa - Key offerings
  • Exhibit 95: Redax Spa - Key customers
  • Exhibit 96: Teleflex Inc. - Vendor overview
  • Exhibit 97: Teleflex Inc. - Business segments
  • Exhibit 98: Teleflex Inc. - Organizational developments
  • Exhibit 99: Teleflex Inc. - Geographic focus
  • Exhibit 100: Teleflex Inc. - Segment focus
  • Exhibit 101: Teleflex Inc. - Key offerings
  • Exhibit 102: Teleflex Inc. - Key customers
  • Exhibit 103: Zimmer Biomet Holdings Inc. - Vendor overview
  • Exhibit 104: Zimmer Biomet Holdings Inc. - Product segments
  • Exhibit 105: Zimmer Biomet Holdings Inc. - Organizational developments
  • Exhibit 106: Zimmer Biomet Holdings Inc. - Geographic focus
  • Exhibit 107: Zimmer Biomet Holdings Inc. - Segment focus
  • Exhibit 108: Zimmer Biomet Holdings Inc. - Key offerings
  • Exhibit 109: Zimmer Biomet Holdings Inc. - Key customers
  • Exhibit 110: Validation techniques employed for market sizing
  • Exhibit 111: Definition of market positioning of vendors
Back to Top